All In Biotech

Drug Trial Radar · NCT04616326

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study

Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 312 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

312

Actual

Start

Nov 25, 2020

Primary completion

Dec 10, 2025

Study completion Mar 2027

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Nov 4, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.

Conditions

  • Chronic Migraine

Interventions

  • GalcanezumabDrug

    Administered SQ

  • PlaceboDrug

    Administered SQ

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in the Number of Monthly Migraine Headache DaysTime frame: Baseline, 3 Months

Locations

88 sites in 11 countries. Site status is shown where the registry gives one.

  • Rehabilitation & Neurological Services

    Huntsville, Alabama

  • 21st Century Neurology, a Division of Xenoscience, Inc.

    Phoenix, Arizona

  • Phoenix Children's Hospital

    Phoenix, Arizona

  • Center for Neurosciences

    Tucson, Arizona

  • Miller Children's & Women's Hospital Long Beach

    Long Beach, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Northwest Florida Clinical Research Group

    Gulf Breeze, Florida

  • Clinical Neuroscience Solutions, Inc. dba CNS Healthcare

    Jacksonville, Florida

  • Vitaly Clinical Research

    Miami, Florida

  • EMDA Clinical Research

    Miami, Florida

  • Bio-Medical Research LLC

    Miami, Florida

  • Allied Biomedical Research Institute

    Miami, Florida

  • Ezy Medical Research

    Miami Lakes, Florida

  • Wellness Clinical Research

    Miami Lakes, Florida

  • Avanza Medical Research Center

    Pensacola, Florida

  • D&H Tamarac Research Center

    Tamarac, Florida

  • Infinity Life Research Group

    Tamarac, Florida

  • USF Health

    Tampa, Florida

  • Palm Beach Research Center

    West Palm Beach, Florida

  • Medical Research Partners

    Ammon, Idaho

  • Northwest Clinical Trials

    Boise, Idaho

  • St. Alexius Medical Center

    Hoffman Estates, Illinois

  • Ascension Via Christi Research

    Wichita, Kansas

  • University of Kentucky Chandler Medical Center

    Lexington, Kentucky

  • Pharmasite Research, Inc.

    Baltimore, Maryland

  • MedVadis Research Corporation

    Waltham, Massachusetts

  • Minneapolis Clinic of Neurology - Burnsville Office

    Burnsville, Minnesota

  • Precise Research Centers

    Flowood, Mississippi

  • Proven Endpoints

    Ridgeland, Mississippi

  • Children Mercy Pediatric Clinical Research Unit

    Kansas City, Missouri

  • Saint Peter's University Hospital

    New Brunswick, New Jersey

  • Dent Neurologic Institute

    Amherst, New York

  • Cohen Children's Northwell Health Physician Partners - Pediatric Neurology

    New Hyde Park, New York

  • Velocity Clinical Research at Raleigh Neurology

    Raleigh, North Carolina

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Headache Center of Hope

    Cincinnati, Ohio

  • Providence Health & Services

    Portland, Oregon

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • Coastal Pediatric Research

    Charleston, South Carolina

  • Access Clinical Trials - Nashville

    Nashville, Tennessee

Showing 40 of 88 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.